Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J Neurosci

Department of Neurology and Center for the Study of the Nervous System Injury, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.34). 08/2002; 22(13):5452-61.
Source: PubMed

ABSTRACT The mechanism underlying the upregulation of NMDA receptor function by group I metabotropic glutamate receptors (mGluRs), including mGluR1 and 5, is not known. Here we show that in cortical neurons, brief selective activation of group I mGluRs with (S)-3,5-dihydroxy-phenylglycine (DHPG) induced a Ca(2+)-calmodulin-dependent activation of Pyk2/CAKbeta and the Src-family kinases Src and Fyn that was independent of protein kinase C (PKC). Activation of Pyk2 and Src/Fyn kinases led to increased tyrosine phosphorylation of NMDA receptor subunits 2A and B (NR2A/B) and was blocked by a selective mGluR1 antagonist, 7-(hydroxyamino)cyclopropa[b]chromen-1a-carboxylate ethyl ester, but not an mGluR5 antagonist, 2-methyl-6-(phenylethynyl)pyridine. Functional linkage between mGluR1 activation and NR2A tyrosine phosphorylation through Pyk2 and Src was also demonstrated after expression of these elements in human embryonic kidney 293 cells. Supporting functional consequences, selective activation of mGluR1 by DHPG induced a potentiation of NMDA receptor-mediated currents that was blocked by inhibiting mGluR1 or Src-family kinases. Furthermore, antagonizing calmodulin or mGluR1, but not PKC, reduced the basal tyrosine phosphorylation levels of Pyk2 and Src, suggesting that mGluR1 may control the basal activity of these kinases and thus the tyrosine phosphorylation levels of NMDA receptors.

Download full-text


Available from: Dennis Choi, Aug 22, 2014
8 Reads
  • Source
    • "6 5% , n 5 7 , P < 0 . 05 versus 2 - AG , Kruskal – Wallis rank sum test followed by the Bonferroni – Dunn multiple - comparison test ) ( Fig . 1C ) . Our lab has previously established that PKC can upregulate NMDAR mediated currents via Src family kinases ( SFKs ) ( Yang et al . , 2009 ; Yang et al . , 2012 ) . We therefore applied PP2 ( 1 lM ) ( Heidinger et al . , 2002 ) , a selective inhibitor of SFKs , in the patch pipette . In the presence of this inhibitor , 2 - AG failed to potentiate NMDAR function ( 2 - AG 1 PP2 : 94 . 7 6 5 . 3% , n5 6 , P < 0 . 05 versus 2 - AG , Kruskal – Wallis rank sum test followed by the Bonferroni – Dunn multiple - comparison test ) ( Fig . 1C ) . In contrast ,"
    [Show abstract] [Hide abstract]
    ABSTRACT: Endocannabinoids (eCBs), including AEA and 2-AG, are endogenous signalling mediators involved in many physiological and pathological events. The G protein-coupled cannabinoid receptor 1 (CB1R) is an important target for eCBs, however additional non-CB1 receptor targets have also been identified. Although recent evidence suggests that NMDA receptor function may be regulated by eCBs, the underlying mechanisms remain poorly characterized. Using acutely isolated CA1 neurons and slices from the hippocampus, we found that both AEA and 2-AG potentiate NMDAR-mediated currents independently of CB1 receptors (CB1Rs) and via distinct signalling pathways. Potentiation by AEA requires the activation of TRPV1 channels. In contrast, potentiation by 2-AG requires the sequential activation of PKC and Src. Additionally, in hippocampal slices, we found that both AEA and 2-AG induce NMDAR-mediated metaplasticity and facilitate the induction of subsequent LTD independently of CB1Rs. Enhanced LTD by AEA, but not 2-AG, was dependent on TRPV1 channels. Our findings reveal previously unrecognized non-CB1R-dependent signalling cascades through which the two major eCBs regulate NMDA receptor function and consequently synaptic plasticity. © 2014 Wiley Periodicals, Inc.
    Hippocampus 12/2014; 24(12). DOI:10.1002/hipo.22339 · 4.16 Impact Factor
  • Source
    • "One such stimulus for PTK2B activation is changes in intracellular calcium levels, which are disrupted in AD brains [76, 78]. PTK2B indirectly regulates N-methyl-D-aspartate receptor (NMDAR) activity through src kinases [79, 80]. Work in mice suggests that loss of protein tyrosine phosphatase alpha (PTP-α), a regulator of PTK2B, can cause defects in NMDAR processes, including memory [81]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Late-onset Alzheimer's disease (LOAD) is a devastating neurodegenerative disease with no effective treatment or cure. In addition to APOE, recent large genome-wide association studies have identified variation in over 20 loci that contribute to disease risk: CR1, BIN1, INPP5D, MEF2C, TREM2, CD2AP, HLA-DRB1/HLA-DRB5, EPHA1, NME8, ZCWPW1, CLU, PTK2B, PICALM, SORL1, CELF1, MS4A4/MS4A6E, SLC24A4/RIN3,FERMT2, CD33, ABCA7, CASS4. In addition, rare variants associated with LOAD have also been identified in APP, TREM2 and PLD3 genes. Previous research has identified inflammatory response, lipid metabolism and homeostasis, and endocytosis as the likely modes through which these gene products participate in Alzheimer's disease. Despite the clustering of these genes across a few common pathways, many of their roles in disease pathogenesis have yet to be determined. In this review, we examine both general and postulated disease functions of these genes and consider a comprehensive view of their potential roles in LOAD risk.
    06/2014; 2(2):85-101. DOI:10.1007/s40142-014-0034-x
  • Source
    • "If mGluR5 serves as a bridge between PrP C and Fyn, then it is predicted to interact physically with both. We confirmed an association of mGluR5 with Fyn (Heidinger et al., 2002), and observed no alteration by PrP C or Abo (Figure S2A). Both mGluR1 and mGluR5 associate with Fyn, but mGluR8 does not (Figure S2B). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Soluble amyloid-β oligomers (Aβo) trigger Alzheimer's disease (AD) pathophysiology and bind with high affinity to cellular prion protein (PrP(C)). At the postsynaptic density (PSD), extracellular Aβo bound to lipid-anchored PrP(C) activates intracellular Fyn kinase to disrupt synapses. Here, we screened transmembrane PSD proteins heterologously for the ability to couple Aβo-PrP(C) with Fyn. Only coexpression of the metabotropic glutamate receptor, mGluR5, allowed PrP(C)-bound Aβo to activate Fyn. PrP(C) and mGluR5 interact physically, and cytoplasmic Fyn forms a complex with mGluR5. Aβo-PrP(C) generates mGluR5-mediated increases of intracellular calcium in Xenopus oocytes and in neurons, and the latter is also driven by human AD brain extracts. In addition, signaling by Aβo-PrP(C)-mGluR5 complexes mediates eEF2 phosphorylation and dendritic spine loss. For mice expressing familial AD transgenes, mGluR5 antagonism reverses deficits in learning, memory, and synapse density. Thus, Aβo-PrP(C) complexes at the neuronal surface activate mGluR5 to disrupt neuronal function.
    Neuron 09/2013; 79(5):887-902. DOI:10.1016/j.neuron.2013.06.036 · 15.05 Impact Factor
Show more